Is there a role for a post-operative boost in a patient with rectal cancer who has a positive margin after total neoadjuvant chemo and chemoradiation therapy?  

Total neoadjuvant therapy consisted of with FOLFOX and chemoradiation therapy with Xeloda and 50.4 Gy.

Would you deliver a boost to the area and if so, to what dose?



Answer from: Radiation Oncologist at Academic Institution
Comments
Radiation Oncologist at Emeritus Professor
Agree in general with @Joel E. Tepper's comments a...
Radiation Oncologist at Memorial Sloan-Kettering Cancer Center
There is very good paper from Korea that addresses...
Sign in or Register to read more